The Liver Meeting 2019-Debate: Post Transplant Recurrence: Does it Matter??

Debate: Post Transplant Recurrence: Does it Matter??

Video Transcription

Video Summary

The speaker addresses the importance of recurrent non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in liver transplant recipients. They highlight the lack of substantial data on the impact of recurrent disease on patient outcomes. The focus is on distinguishing between allograft steatosis and underlying NASH as factors affecting survival and cardiovascular events post-transplant. The need for more comprehensive studies in this area is emphasized, with ongoing research efforts aimed at providing a clearer picture of the implications of recurrent NASH. Despite concerns about weight gain and addiction issues post-transplant, the decision to transplant patients with NASH remains a complex and evolving topic.

Asset Caption

Presenter: Kymberly Watt

Keywords

non-alcoholic fatty liver disease

NAFLD

non-alcoholic steatohepatitis

NASH

liver transplant recipients